Hims Just Launched an Ozempic Dupe
US$ 22.47
semaglutide self pay Novo Nordisk launches introductory self-pay offer for Wegovy® and Ozempic® for $199 per month Novo Nordisk launches introductory self-pay
Description
Some studies have concluded that the use of GLP-1RAs demonstrates no association with an increased risk of pancreatic cancer [7, 26, 27]
Wegovy is a brand name for semaglutide, a medication approved for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity
2025;48(Suppl 1):S1S350
Hayes MR, Schmidt HD
why not be the next
A lot of it isnt because they dont get sick
